Association of ApoE polymorphisms with prevalent hypertension in 1406 older adults: the Bambuí Health Aging Study (BHAS)
Apolipoprotein E (ApoE) polymorphism influences lipid metabolism, but its association with arterial hypertension is controversial. The objective of this study was to examine the association between ApoE polymorphism and prevalent hypertension in a large unselected population of older adults. Partici...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Associação Brasileira de Divulgação Científica
2008-02-01
|
Series: | Brazilian Journal of Medical and Biological Research |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2008000200002 |
_version_ | 1818549706336239616 |
---|---|
author | A.K. Fuzikawa S.V. Peixoto M. Taufer E.H. Moriguchi M.F. Lima-Costa |
author_facet | A.K. Fuzikawa S.V. Peixoto M. Taufer E.H. Moriguchi M.F. Lima-Costa |
author_sort | A.K. Fuzikawa |
collection | DOAJ |
description | Apolipoprotein E (ApoE) polymorphism influences lipid metabolism, but its association with arterial hypertension is controversial. The objective of this study was to examine the association between ApoE polymorphism and prevalent hypertension in a large unselected population of older adults. Participants from the baseline of the Bambuí Health Aging Study whose ApoE genes had been genotyped were selected for this study (N = 1406, aged 60-95 years). These subjects represented 80.7% of the total elderly residents in Bambuí city, MG, Brazil. Hypertension was defined as a systolic blood pressure ³140 mmHg and/or a diastolic blood pressure ³90 mmHg, or the use of anti-hypertensive medication. The exposure variable was the ApoE genotype as follows: e3 carriers, e3e3; e2 carriers, e2e2 or e2e3, and e4 carriers, e3e4 or e4e4. Potential confounding variables were age, gender, traditional cardiovascular risk factors, uric acid, and creatinine levels. The prevalence of hypertension was 61.3%. Compared with the e3 homozygotes, neither the e2 nor the e4 carrier status was associated with hypertension (adjusted prevalence ratios = 0.94, 95%CI = 0.83-1.07 and 0.98, 0.89-1.07, respectively). On the other hand, the e2 allele carriers had lower LDL cholesterol levels (P < 0.001) and the e4 carriers had higher LDL cholesterol levels (P = 0.036). This study provides epidemiologic evidence that the ApoE genotype is not associated with prevalent hypertension in old age. |
first_indexed | 2024-12-12T08:36:51Z |
format | Article |
id | doaj.art-4af016a35bc24b1d84d84c46696ed010 |
institution | Directory Open Access Journal |
issn | 0100-879X 1414-431X |
language | English |
last_indexed | 2024-12-12T08:36:51Z |
publishDate | 2008-02-01 |
publisher | Associação Brasileira de Divulgação Científica |
record_format | Article |
series | Brazilian Journal of Medical and Biological Research |
spelling | doaj.art-4af016a35bc24b1d84d84c46696ed0102022-12-22T00:30:54ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research0100-879X1414-431X2008-02-014128994Association of ApoE polymorphisms with prevalent hypertension in 1406 older adults: the Bambuí Health Aging Study (BHAS)A.K. FuzikawaS.V. PeixotoM. TauferE.H. MoriguchiM.F. Lima-CostaApolipoprotein E (ApoE) polymorphism influences lipid metabolism, but its association with arterial hypertension is controversial. The objective of this study was to examine the association between ApoE polymorphism and prevalent hypertension in a large unselected population of older adults. Participants from the baseline of the Bambuí Health Aging Study whose ApoE genes had been genotyped were selected for this study (N = 1406, aged 60-95 years). These subjects represented 80.7% of the total elderly residents in Bambuí city, MG, Brazil. Hypertension was defined as a systolic blood pressure ³140 mmHg and/or a diastolic blood pressure ³90 mmHg, or the use of anti-hypertensive medication. The exposure variable was the ApoE genotype as follows: e3 carriers, e3e3; e2 carriers, e2e2 or e2e3, and e4 carriers, e3e4 or e4e4. Potential confounding variables were age, gender, traditional cardiovascular risk factors, uric acid, and creatinine levels. The prevalence of hypertension was 61.3%. Compared with the e3 homozygotes, neither the e2 nor the e4 carrier status was associated with hypertension (adjusted prevalence ratios = 0.94, 95%CI = 0.83-1.07 and 0.98, 0.89-1.07, respectively). On the other hand, the e2 allele carriers had lower LDL cholesterol levels (P < 0.001) and the e4 carriers had higher LDL cholesterol levels (P = 0.036). This study provides epidemiologic evidence that the ApoE genotype is not associated with prevalent hypertension in old age.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2008000200002Apolipoprotein EHypertensionLow-density lipoprotein cholesterolTriglyceridesLipid metabolism |
spellingShingle | A.K. Fuzikawa S.V. Peixoto M. Taufer E.H. Moriguchi M.F. Lima-Costa Association of ApoE polymorphisms with prevalent hypertension in 1406 older adults: the Bambuí Health Aging Study (BHAS) Brazilian Journal of Medical and Biological Research Apolipoprotein E Hypertension Low-density lipoprotein cholesterol Triglycerides Lipid metabolism |
title | Association of ApoE polymorphisms with prevalent hypertension in 1406 older adults: the Bambuí Health Aging Study (BHAS) |
title_full | Association of ApoE polymorphisms with prevalent hypertension in 1406 older adults: the Bambuí Health Aging Study (BHAS) |
title_fullStr | Association of ApoE polymorphisms with prevalent hypertension in 1406 older adults: the Bambuí Health Aging Study (BHAS) |
title_full_unstemmed | Association of ApoE polymorphisms with prevalent hypertension in 1406 older adults: the Bambuí Health Aging Study (BHAS) |
title_short | Association of ApoE polymorphisms with prevalent hypertension in 1406 older adults: the Bambuí Health Aging Study (BHAS) |
title_sort | association of apoe polymorphisms with prevalent hypertension in 1406 older adults the bambui health aging study bhas |
topic | Apolipoprotein E Hypertension Low-density lipoprotein cholesterol Triglycerides Lipid metabolism |
url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2008000200002 |
work_keys_str_mv | AT akfuzikawa associationofapoepolymorphismswithprevalenthypertensionin1406olderadultsthebambuihealthagingstudybhas AT svpeixoto associationofapoepolymorphismswithprevalenthypertensionin1406olderadultsthebambuihealthagingstudybhas AT mtaufer associationofapoepolymorphismswithprevalenthypertensionin1406olderadultsthebambuihealthagingstudybhas AT ehmoriguchi associationofapoepolymorphismswithprevalenthypertensionin1406olderadultsthebambuihealthagingstudybhas AT mflimacosta associationofapoepolymorphismswithprevalenthypertensionin1406olderadultsthebambuihealthagingstudybhas |